metyrapone has been researched along with Cerebrovascular Disorders in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HENDERSON, HR | 1 |
| GILROY, J | 1 |
| MEYER, JS | 1 |
| Kawiak, W | 1 |
2 other studies available for metyrapone and Cerebrovascular Disorders
| Article | Year |
|---|---|
PITUITARY FUNCTION IN PATIENTS WITH CEREBROVASCULAR DISEASE (STROKE).
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Biomedical Research; Blood; Cerebrovascu | 1964 |
[Activity of the hypothalamo-hypophyseal-adrenal system and of certain metabolic regulatory mechanisms in early acute disorders of the brain].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Cerebrovascular Disorders; | 1969 |